| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.24 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |